Skip to content

IPHA

Innate Pharma SA

NASDAQ · Healthcare · Biotechnology · FR

$1.90
−0.52%
Ask drillr
Institutional positioning

13F filings over the trailing two quarters

New 4Increased 2Reduced 9Sold out 2
FilerActionSharesFiled
Lion Point Capital, LPUnchanged81,151Aug 14, 2026
LION POINT CAPITAL, LPUnchanged81,151May 15, 2026
MORGAN STANLEYReduced43,524May 15, 2026
MORGAN STANLEYUnchanged43,524Aug 13, 2026
JANE STREET GROUP, LLCReduced43,365May 12, 2026
SmartHarvest Portfolios, LLCNew Position23,750Aug 4, 2026
XTX Topco LtdNew Position15,130Aug 14, 2026
CITADEL ADVISORS LLCNew Position12,441Sep 2, 2026
JANE STREET GROUP, LLCReduced10,310Aug 14, 2026
MILLENNIUM MANAGEMENT LLCReduced10,064May 15, 2026
RHUMBLINE ADVISERSReduced4,734May 12, 2026
RHUMBLINE ADVISERSReduced4,719Aug 12, 2026
UBS Group AGIncreased1,363Aug 13, 2026
UBS GROUP AGReduced861May 5, 2026
GAMMA INVESTING LLCReduced240Apr 6, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings